AIM Congress
About AIM Congress
AIM Congress is an initiative of the AIM Global Foundation, an independent international organization committed to empowering the world’s economy by boosting effective promotion strategies and facilitating opportunities for economic productivity and expansion. Established as a leading investment platform in the Middle East, AIM Congress aims to ignite positive transformation by creating investment opportunities, upholding solidarity, and developing economic relations among nations. The organization addresses global challenges that have a profound impact on economic growth, bringing together corporate leaders, policymakers, investors, entrepreneurs, academics, and experts to showcase up-to-date information, strategies, and knowledge on attracting investments. AIM Congress continues to gather corporate leaders, policymakers, businessmen, regional and international investors, entrepreneurs, leading academics, and experts showcasing up-to-date information, strategies, and knowledge on attracting investments. This brings together visitors from both the public and private sectors in the United Arab Emirates and worldwide.
Investment Mandate
Investment Stages11
Asset Classes11
Geographical Focus
African markets3
Other stated markets17
Requirements
Focus on sectors including Private Equity, Venture Capital, Real Estate, Infrastructure, Commodities, Hedge Funds, Fixed Income (Debt and Bonds), Crypto, Distressed and Special Situations, ESG and Impact Investing, Collectibles & Art, Targeting stages from Pre-Seed to Distressed investments, Geographical focus includes United Arab Emirates, China, Pakistan, Georgia, Angola, Kazakhstan, India, Indonesia, Turkey, Armenia, Lesotho, United States, United Kingdom, Germany, France, Japan, South Korea, India, Brazil, South Africa, and Australia, Industries of interest encompass Technology, Healthcare, Real Estate, Financial Services, Energy, Infrastructure, Education, Tourism, Agriculture, Manufacturing, Logistics, Transportation, Water Technology, Biotechnology, and Pharmaceuticals
Stated Portfolio5
As reported by the investor. We hold no profile for these companies, so they are printed as stated rather than linked.
Is this you?
Claim this investor profile to manage your firm's information.
Claim this profileReport an error